SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS IN ARTHRITIS

被引：0
作者：
COPE, AP
MAINI, RN
机构：
[1] CHARING CROSS & WESTMINSTER MED SCH,LONDON,ENGLAND
[2] KENNEDY INST,LONDON W6 7DW,ENGLAND
[3] STANFORD UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,STANFORD,CA 94305
来源：
JOURNAL OF RHEUMATOLOGY | 1995年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：382 / 384
页数：3
相关论文
共 27 条
[1]   CORRELATION BETWEEN SERUM LEVELS OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR AND DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ADERKA, D ;
WYSENBEEK, A ;
ENGELMANN, H ;
COPE, AP ;
BRENNAN, F ;
MOLAD, Y ;
HORNIK, V ;
LEVO, Y ;
MAINI, RN ;
FELDMANN, M ;
WALLACH, D .
ARTHRITIS AND RHEUMATISM, 1993, 36 (08) :1111-1120
[2]   STABILIZATION OF THE BIOACTIVITY OF TUMOR-NECROSIS-FACTOR BY ITS SOLUBLE RECEPTORS [J].
ADERKA, D ;
ENGELMANN, H ;
MAOR, Y ;
BRAKEBUSCH, C ;
WALLACH, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) :323-329
[3]  
ADERKA D, 1992, LYMPHOKINE CYTOK RES, V101, P157
[4]   CIRCULATING SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS, INTERLEUKIN-2 RECEPTORS, TUMOR-NECROSIS-FACTOR-ALPHA, AND INTERLEUKIN-6 LEVELS IN RHEUMATOID-ARTHRITIS - LONGITUDINAL EVALUATION DURING METHOTREXATE AND AZATHIOPRINE THERAPY [J].
BARRERA, P ;
BOERBOOMS, AMT ;
JANSSEN, EM ;
SAUERWEIN, RW ;
GALLATI, H ;
MULDER, J ;
DEBOO, T ;
DEMACKER, PNM ;
VANDEPUTTE, LBA ;
VANDERMEER, JWM .
ARTHRITIS AND RHEUMATISM, 1993, 36 (08) :1070-1079
[5]  
BEMELMANS MHA, 1993, J IMMUNOL, V150, P2007
[6]  
BEMELMANS MHA, 1993, J IMMUNOL, V151, P5554
[7]  
BRENNAN FM, 1992, BRIT J RHEUMATOL, V31, P293
[8]  
BUCHAN G, 1988, CLIN EXP IMMUNOL, V73, P449
[9]  
CHIKANZA IC, 1993, CLIN EXP IMMUNOL, V92, P19
[10]   INCREASED LEVELS OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS IN THE SERA AND SYNOVIAL-FLUID OF PATIENTS WITH RHEUMATIC DISEASES [J].
COPE, AP ;
ADERKA, D ;
DOHERTY, M ;
ENGELMANN, H ;
GIBBONS, D ;
JONES, AC ;
BRENNAN, FM ;
MAINI, RN ;
WALLACH, D ;
FELDMANN, M .
ARTHRITIS AND RHEUMATISM, 1992, 35 (10) :1160-1169
123